...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZEN-3694 and Enzalutamide 2b Trial

Well I'm glad I could at least provide you with a good laugh Narmac :).  I have to admit as I was typing that I had to restrain my own eyes from rolling but I would still like to see Don address the comment that he himself made. As we all know too many times he makes remarks and then doesn't address them or hold himself accountable for them at a later date. 

Share
New Message
Please login to post a reply